SynthesisFrontiers in medicine2026
Effectiveness and safety of probiotics in treating knee osteoarthritis: an updated systematic review and meta-analysis of randomized controlled trials.
Synthesis in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Knee osteoarthritis (KOA) is a prevalent degenerative joint disease, and gut microbiota dysbiosis in its pathogenesis is a research hotspot. This study performed a traditional meta-analysis to systematically evaluate probiotics' efficacy (for KOA symptoms, strain-specific superiority) and safety, using RCT data from Chinese and English databases. Stata 17.0 and RevMan 5.4 analyzed outcomes including patient-reported pain (Visual Analog Scale (VAS), WOMAC pain), joint stiffness, function limitation, serum High-sensitivity C-reactive protein (hs-CRP), and safety. Probiotics showed no significant adverse event differences vs. placebo, with no serious safety issues. Results suggest probiotics have potential for KOA, especially
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.